97. 潰瘍性大腸炎 Ulcerative colitis Clinical trials / Disease details


臨床試験数 : 2,630 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-JapicCTI-184008
28/8/201821/06/2018A Multicenter, Randomized, Double-Blind, Placebo Controlled 52-Week Maintenance and an Open-Label Extension Study of the Efficacy and Safety of Risankizumab in Subjects With Ulcerative Colitis Who Responded to Induction Treatment in M16-067 or M16-065 [M16-066]A Multicenter, Randomized, Double-Blind, Placebo Controlled 52-Week Maintenance and an Open-Label Extension Study of the Efficacy and Safety of Risankizumab in Subjects With Ulcerative Colitis Who Responded to Induction Treatment in M16-067 or M16-065 [M16-066] Ulcerative Colitis (UC)Intervention name : Risankizumab (Genetical Recombination)
INN of the intervention : risankizumab
Dosage And administration of the intervention : SC/IV
Control intervention name : -
INN of the control intervention : -
Dosage And administration of the control intervention : -
AbbVie GKNULLrecruiting1680BOTH70Phase 3Japan, Asia except Japan, North America, South America, Europe, Oceania, Africa
2JPRN-JapicCTI-183997
29/5/201812/06/2018A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Ulcerative Colitis Who Have Failed Prior Biologic Therapy [M16-067]A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Ulcerative Colitis Who Have Failed Prior Biologic Therapy [M16-067] Ulcerative Colitis (UC)Intervention name : Risankizumab (Genetical Recombination)
INN of the intervention : risankizumab
Dosage And administration of the intervention : SC/IV
Control intervention name : -
INN of the control intervention : -
Dosage And administration of the control intervention : -
AbbVie GKNULLrecruiting1680BOTH65Phase 2-3Japan, Asia except Japan, North America, South America, Europe, Oceania, Africa